Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
Clinical trial NCT06231017 · UNKNOWN
Trial details
- NCT number
- NCT06231017
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-19
- Primary completion
- 2025-01-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.